| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |